Browse > Article
http://dx.doi.org/10.4046/trd.2020.0029

Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease  

Hwang, Hun-Gyu (Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University Gumi Hospital)
Kim, Yang-Ki (Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University Seoul Hospital)
Kim, Myung-Shin (Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University Gumi Hospital)
Lim, Gune-Il (Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University Gumi Hospital)
Schulman, Sam (Division of Hematology and Thromboembolism, Department of Medicine, Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences (Hamilton General Site), McMaster University)
Publication Information
Tuberculosis and Respiratory Diseases / v.83, no.3, 2020 , pp. 255-256 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Dobromirski M, Cohen AT. How I manage venous thromboembolism risk in hospitalized medical patients. Blood 2012;120:1562-9.   DOI
2 Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011;9:85-91.   DOI
3 Hwang HG, Choi WI, Lee B, Lee CW. Incidence and risk factors of recurrent venous thromboembolism after pulmonary embolism. Tuberc Respir Dis 2019;82:341-7.   DOI
4 Hwang HG, Schulman S. Respiratory review of 2013: pulmonary thromboembolism. Tuberc Respir Dis 2013;75:89-94.   DOI
5 Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010;8:2105-12.   DOI
6 Kim H, Jeon B. Developing a framework for performance assessment of the public long-term care system in Korea: methodological and policy lessons. Health Res Policy Syst 2020;18:27.   DOI
7 Kim YK. Predictors of recurrent venous thromboembolism after pulmonary embolism in Korea. Tuberc Respir Dis 2019;82:357-8.   DOI
8 Lee GD, Ju S, Kim JY, Kim TH, Yoo JW, Lee SJ, et al. Risk factor and mortality in patients with pulmonary embolism combined with infectious disease. Tuberc Respir Dis 2020;83:157-66.   DOI
9 Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164:963-8.   DOI
10 Clayton TC, Gaskin M, Meade TW. Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol 2011;40:819-27.   DOI
11 Cohen AT, Spiro TE, Buller HR, Haskell L, Hu D, Hull R, et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013;368:513-23.   DOI
12 Mahlab-Guri K, Otman MS, Replianski N, Rosenberg-Bezalel S, Rabinovich I, Sthoeger Z. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: a real life experience. Medicine (Baltimore) 2020;99:e19127.   DOI
13 Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, et al. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med 2018;379:1118-27.   DOI
14 Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 2004;57:1254-7.   DOI
15 Cohen AT, Edmondson RA, Phillips MJ, Ward VP, Kakkar VV. The changing pattern of venous thromboembolic disease. Haemostasis 1996;26:65-71.